# Study Evaluating IMA-026 in Healthy Subjects

> **NCT00517348** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 50 (estimated)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** IMA-026

## Key facts

- **NCT ID:** NCT00517348
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2009-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00517348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00517348, "Study Evaluating IMA-026 in Healthy Subjects". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00517348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*